According to estimates of German concern Bayer, its sales for the current year will amount to 44 billion 600 million euros. And next year, the company expects growth of 4% to 46 billion euros. The company plans that in subsequent years until 2022, the annual sales increase will average 4-5%. Werner Baumann, Chairman of the Board of Management of Bayer, stated that the forecast was based on the transformation of the main brands in the health care and food additives units. The company has already sold the veterinary drugs division and now intends to sell the business of manufacturing foot care products and accessories. The company's cost reduction program also includes the sale of a 60% stake in Currenta and a reduction of around 12,000 employees worldwide.
Backed by record-low mortgage rates, U.S. home sales reached its strongest record in June. However, the outlook for the housing market remained murky as low inventory and high unemployment rate pressed amid the virus crisis. Existing home ...
Australian retail sales advanced 2.4% in June. This came as an upbeat figure following a 16.5% increase seen in May as the land down under resumed its economic operations from coronavirus-related lockdowns. The country’s retail sales ...
After a record decline seen last quarter, Britain’s economy is expected to grow at its most rapid pace in decades. The recovery is likely as large portions of the economy resumed operations after coronavirus-related lockdowns were lifted. Despite ...
Renault SA (RENA.PA) announced on Monday that its global car sales fell by 34.9% in the first half of the year due to the impact of the coronavirus pandemic. However, the company said that it had seen some signs of recovery in June. The French ...
European new car registrations fell in June year-on-year, but showed some improvement when compared to May 2020 as lockdown measures continue to loosen across the region, Tuesday’s industry data showed. In June, passenger car sales were ...